NCT03343054 2024-08-22A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid TumorsPfizerPhase 1 Completed28 enrolled 43 charts
NCT04635631 2023-10-10STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORSPfizerPhase 1 Completed15 enrolled 38 charts
NCT02921919 2022-08-24Open-Label Extension and Safety Study of TalazoparibPfizerPhase 2 Completed120 enrolled 16 charts